Skip to main content

Sample of major publications from the Bernstein Laboratory

  • Retinal bioavailability and Functional Effects of a Synthetic Very-Long-Chain Polyunsaturated Fatty Acid in Mice. Gorusupudi A, Rallabandi R, Li B, Arunkumar R, Blount JD, Rognon GT, Chang FY, Wade A, Lucas S, Conboy JC, Rainier JD, Bernstein PS. Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):e2017739118.
  • Longitudinal Fluorescence Lifetime Imaging Ophthalmoscopy Analysis in Patients with Macular Telangiectasia Type 2 (Mactel). Sauer L, Vitale AS, Modersitzki NK, Bernstein PS. Retina. 2021 Jul 1;41(7):1416-1427.
  • Lutein and Zeaxanthin Reduce A2E and Iso-A2E Levels and Improve Visual Performance in Abca4-/-/Bco2-/- Double Knockout Mice. Arunkumar R, Gorusupudi A, Li B, Blount JD, Nwagbo U, Kim HJ, Sparrow JR, Bernstein PS. Exp Eye Res. 2021 Jun 20;209:108680.
  • Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation. Hubbard A.F., Askew E.W., Singh N., Leppert M., Bernstein P.S. (2006). Arch Ophthalmol, 124(2), 257-63.
  • Non-Mydriatic Fluorescence-Based Quantitative Imaging of Human Macular Pigment Distributions. Sharifzadeh M, Bernstein P.S., Gellermann W. (2006). J Opt Soc Am A, in press.
  • Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye.  Bhosale P., Larson A.J., Frederick J.M., Southwick K., Thulin C.D., Bernstein P.S. (2004). J Biol Chem, 279(47), 49447-54.
  • Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Bhosale P., Bernstein P.S. (2005). Biochim Biophys Acta, 1740(2), 116-21.
  • Method and apparatus for Raman imaging of macular pigments. McClane R.W., Gellermann W, Bernstein P.S.: (2006) US Patent No. 7,039,452.